Menu
Search
|

Menu

Close
X

Sanofi SA SASY.PA (Paris Stock Exchange)

64.30 EUR
-- (--)
As of Feb 19
chart
Previous Close 64.30
Open --
Volume --
3m Avg Volume 2,523,973
Today’s High --
Today’s Low --
52 Week High 92.97
52 Week Low 63.09
Shares Outstanding (mil) 1,262.50
Market Capitalization (mil) 108,903.00
Forward P/E 23.32
Dividend (Yield %) 2.96 ( 3.43 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.43 Mean rating from 28 analysts

KEY STATS

Revenue (mm, EUR)
FY17
27,223
FY16
44,003
FY15
43,922
EPS (EUR)
FY17
3.020
FY16
4.679
FY15
4.587
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.32
32.90
Price to Sales (TTM)
vs sector
3.00
5.77
Price to Book (MRQ)
vs sector
1.88
5.41
Price to Cash Flow (TTM)
vs sector
16.51
23.42
Total Debt to Equity (MRQ)
vs sector
32.01
16.52
LT Debt to Equity (MRQ)
vs sector
26.39
12.22
Return on Investment (TTM)
vs sector
5.69
14.43
Return on Equity (TTM)
vs sector
8.50
16.13

EXECUTIVE LEADERSHIP

Serge Weinberg
Independent Chairman of the Board, Since 2015
Salary: €700,000.00
Bonus: --
Olivier Brandicourt
Chairman of the Executive Committee, Chief Executive Officer, Director, Since 2015
Salary: €895,455.00
Bonus: --
Jerome Contamine
Executive Vice President, Chief Financial Officer, Member of the Executive Committee, Since 2009
Salary: --
Bonus: --
Karen Linehan
Executive Vice President, Legal Affairs and General Counsel; Member of the Executive Committee, Since 2014
Salary: --
Bonus: --
Olivier Charmeil
Executive Vice President and General Manager, General Medicines & Emerging Markets; Member of the Executive Committee, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

54 rue la Boetie
PARIS     75008

Phone: +331.53774000

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.

SPONSORED STORIES